Heart and kidney diseases are on the rise in Malaysia — claiming lives silently and often too soon. In response, Alpro Group, with the support of Boehringer Ingelheim has launched Jaga CarDia, part of the “Sihat Sama-Sama” initiatives with Boehringer Ingelheim — a nationwide blood screening initiative dedicated to early screening and prevention of chronic diseases. By focusing on early detection instead of late intervention, Jaga CarDia aims to shift the nation’s mindset from treatment to prevention — helping Malaysians take control of their health before silent damage becomes irreversible.
More than just a screening, Jaga CarDia is a call to action — encouraging Malaysians to care for their hearts, kidneys, and overall health together as families. Because good health doesn’t begin with treatment — it begins with awareness. Early Detection Starts Now. ❤️
